LINCOLN, Neb. (AP) – Nebraska will get more than $2.2 million from a settlement with drugmaker GlaxoSmithKline PLC over substandard prescription medicines.
A GlaxoSmithKline subsidiary in Puerto Rico, SB Pharmaco, which made the drugs, agreed in October to plead guilty to a felony and pay $150 million in criminal fines and forfeitures. A lawsuit had claimed that four medications – Paxil CR, Avandamet, Kytril and Bactroban – did not meet FDA standards for strength, purity or quality.
Attorney General Jon Bruning announced Thursday the state’s share of the settlement, which will come as a Medicaid reimbursement.
Date: December 9, 2010
Source: Associated Press
